首页> 外文OA文献 >Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women
【2h】

Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women

机译:多国绝经后妇女最近脆性骨折后骨质疏松症药物治疗的预测因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

OBJECTIVES: To determine the proportion of untreated women who reported receiving treatment after incident fracture and to identify factors that predict treatment across an international spectrum of individuals.DESIGN: Prospective observational study. Self-administered questionnaires were mailed at baseline and 1 year.SETTING: Multinational cohort of noninstitutionalized women recruited from 723 primary physician practices in 10 countries.PARTICIPANTS: Sixty thousand three hundred ninety-three postmenopausal women aged 55 and older were recruited with a 2:1 oversampling of women aged 65 and older.MEASUREMENTS: Data collected included participant demographics, medical history, fracture occurrence, medications, and risk factors for fracture. Anti-osteoporosis medications (AOMs) included estrogen, selective estrogen receptor modulators, bisphosphonates, calcitonin, parathyroid hormone, and strontium.RESULTS: After the first year of follow-up, 1,075 women reported an incident fracture. Of these, 17% had started AOM, including 15% of those with a single fracture and 35% with multiple fractures. Predictors of treatment included baseline calcium use (P = .01), baseline diagnosis of osteoporosis (P \u3c .001), and fracture type (P \u3c .001). In multivariable analysis, women taking calcium supplements at baseline (odds ratio (OR) = 1.67) and with a baseline diagnosis of osteoporosis (OR = 2.55) were more likely to be taking AOM. Hip fracture (OR = 2.61), spine fracture (OR = 6.61), and multiple fractures (OR = 3.79) were associated with AOM treatment. Age, global region, and use of high-risk medications were not associated with treatment.CONCLUSION: More than 80% of older women with new fractures were not treated, despite the availability of AOM. Important factors associated with treatment in this international cohort included diagnosis of osteoporosis before the incident fracture, spine fracture, and to a lesser degree, hip fracture. Geriatrics Society.
机译:目的:确定发生骨折后报告接受治疗的未经治疗妇女的比例,并确定预测国际范围内个体接受治疗的因素。设计:一项前瞻性观察性研究。在基线和1年时寄出自我管理的问卷。地点:从10个国家的723名主要医师中招募的多国非机构化妇女队列。参与者:653名55岁及以上的绝经后妇女,其中2分: 1例65岁及以上女性的过采样。测量:收集的数据包括参与者的人口统计学,病史,骨折发生,用药和骨折危险因素。抗骨质疏松症药物(AOM)包括雌激素,选择性雌激素受体调节剂,双膦酸盐,降钙素,甲状旁腺激素和锶。结果:随访的第一年后,有1,075名妇女报告了骨折事件。其中,有17%的患者开始了AOM,其中15%的患者为单发骨折,35%的患者为多发骨折。治疗的预测因素包括基线钙使用量(P = .01),骨质疏松症的基线诊断(P \ u3c .001)和骨折类型(P \ u3c .001)。在多变量分析中,基线时服用钙补充剂(优势比(OR)= 1.67)且基线诊断为骨质疏松症(OR = 2.55)的女性更有可能服用AOM。髋骨骨折(OR = 2.61),脊柱骨折(OR = 6.61)和多发性骨折(OR = 3.79)与AOM治疗相关。年龄,全球区域和高危药物的使用与治疗无关。结论:尽管有AOM,但仍有80%以上的新骨折老年妇女未得到治疗。在这一国际队列中,与治疗相关的重要因素包括在发生骨折,脊柱骨折以及较小程度的髋部骨折之前诊断出骨质疏松症。老年医学会。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号